Trade DNA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Ginkgo Bioworks Holdings, Inc. (DNA) is trading at US$6.96, down 4.13% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$498.32M. Over the past 52 weeks, DNA has traded between US$5.37 and US$17.58. On Syfe you can trade DNA with $0 commission and add it to your watchlist.
| Previous close | US$7.26 |
|---|---|
| Market cap | US$498.32M |
| 52-week range | US$5.37 – US$17.58 |
| Volume | 1.25M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.
Year: 2021
Ginkgo Bioworks Holdings, Inc. (DNA) stock is trading at US$6.96, -4.13% from the previous close of US$7.26.
The market cap for Ginkgo Bioworks Holdings, Inc. (DNA) stock is approximately US$498.32M.
The 52-week high for Ginkgo Bioworks Holdings, Inc. (DNA) stock is US$17.58.
The 52-week low for Ginkgo Bioworks Holdings, Inc. (DNA) stock is US$5.37.
Ginkgo Bioworks Holdings, Inc. (DNA) does not currently pay a dividend.
Stay on top of DNA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
